Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Acorda Therapeutics, Inc.
FDA Inspection
•Acorda Therapeutics, Inc.•September 9, 2011

Acorda Therapeutics, Inc. – FDA Inspection, Sep 9, 2011

Record Details

This FDA Inspection record concerns Acorda Therapeutics, Inc., with an inspection on September 9, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Acorda Therapeutics, Inc.
Inspection Date
September 9, 2011
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · bc21c245-952e-45c0-ab6e-a9fbc9f76afb

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
739375
FDA center
Human Drugs
Project area
Bioresearch Monitoring

FDA Citations

10
  1. 21 CFR 314.80(c)Failure by applicant to report ADE
  2. 21 CFR 314.80(b)Failure to review ADE information
  3. 21 CFR 314.80(c)(1)(ii)Failure to investigate serious, unexpected events
  4. 21 CFR 314.80(e)Failure to report post-marketing study ADEs
  5. 21 CFR 314.80(c)(2)Failure to report non-alert ADEs
  6. 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
  7. 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
  8. 21 CFR 314.80(j)Failure to maintain records
  9. 21 CFR 314.80(b)Failure to develop written procedures
  10. 21 CFR 314.80(c)(1)(iii)Non-applicant reports to applicant

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Acorda Therapeutics, Inc.

10
DateClassificationOfficeProject area
August 18, 2020NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 19, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
January 18, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
February 29, 2016VAICenter for Drug Evaluation and ResearchBioresearch Monitoring
August 25, 2014VAICenter for Drug Evaluation and ResearchBioresearch Monitoring
View all 10 other inspections on the company page
Other documents for Acorda Therapeutics, Inc.
  • FDA Inspection 1130049 - 2020-08-18
  • FDA Inspection 1100682 - 2019-07-19
  • FDA Inspection 1079179 - 2019-01-18
  • FDA Inspection 975465 - 2016-02-29
  • FDA Inspection 892026 - 2014-08-25

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Acorda Therapeutics, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.